Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Leukemia|January 6, 2018
Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemiaS Jo, J H Lee, J J Mattei, et al.Bone Marrow Transplantation|December 21, 2004
Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003M A Pulsipher, J E Levine, R J Hayashi, et al.Nature Medicine|December 13, 1997
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple speciesM A Goodell, M Rosenzweig, H Kim, et al.Stem Cells (Dayton, Ohio)|September 1, 1996
Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primatesF J Schlerman, A G Bree, M D Kaviani, et al.Bone Marrow Transplantation|March 2, 2010
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031G D E Cuvelier, A Kariminia, H Fujii, et al.Bone Marrow Transplantation|May 12, 2015
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?M A Pulsipher, B Langholz, D A Wall, et al.Bone Marrow Transplantation|April 17, 2012
Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology GroupS F Sencer, T Zhou, L S Freedman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastomaS A Grupp, J W Stern, N Bunin, et al.Bone Marrow Transplantation|January 22, 2013
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1A E Seif, A Naranjo, D L Baker, et al.Leukemia|August 17, 2011
Endogenous knockdown of survivin improves chemotherapeutic response in ALL modelsD J Morrison, L E Hogan, G Condos, et al.Pageof 4